Skip to Content

Join the 'Cholesterol' group to help and get support from people like you.

Cholesterol News

FDA Approves Juxtapid - New Orphan Drug for Rare Cholesterol Disorder

Posted 26 Dec 2012 by

December 26, 2012 – On Dec. 21, the U.S. Food and Drug Administration approved Juxtapid (lomitapide) to reduce low-density lipoprotein (LDL) cholesterol, total cholesterol, apolipoprotein B, and non-high-density lipoprotein (non-HDL) cholesterol in patients with homozygous familial hypercholesterolemia (HoFH). Juxtapid is intended for use in combination with a low fat diet and other ...

Ask a Question